Correlation Between Pmv Pharmaceuticals and NewAmsterdam Pharma

Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and NewAmsterdam Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and NewAmsterdam Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pmv Pharmaceuticals and NewAmsterdam Pharma, you can compare the effects of market volatilities on Pmv Pharmaceuticals and NewAmsterdam Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of NewAmsterdam Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and NewAmsterdam Pharma.

Diversification Opportunities for Pmv Pharmaceuticals and NewAmsterdam Pharma

0.58

Correlation Coefficient

Pmv Pharmaceuticals  NewAmsterdam Pharma

Very weak diversification

The 3 months correlation between Pmv and NewAmsterdam is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and NewAmsterdam Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NewAmsterdam Pharma and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with NewAmsterdam Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NewAmsterdam Pharma has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and NewAmsterdam Pharma go up and down completely randomly.

Pair Corralation between Pmv Pharmaceuticals and NewAmsterdam Pharma

Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to under-perform the NewAmsterdam Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Pmv Pharmaceuticals is 1.35 times less risky than NewAmsterdam Pharma. The stock trades about -0.03 of its potential returns per unit of risk. The NewAmsterdam Pharma is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  950.00  in NewAmsterdam Pharma on September 15, 2024 and sell it today you would earn a total of  1,559  from holding NewAmsterdam Pharma or generate 164.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Pmv Pharmaceuticals  vs.  NewAmsterdam Pharma

Pmv Pharmaceuticals

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Pmv Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, Pmv Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

NewAmsterdam Pharma

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in NewAmsterdam Pharma are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak primary indicators, NewAmsterdam Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pmv Pharmaceuticals and NewAmsterdam Pharma

The main advantage of trading using opposite Pmv Pharmaceuticals and NewAmsterdam Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, NewAmsterdam Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NewAmsterdam Pharma will offset losses from the drop in NewAmsterdam Pharma's long position.

The idea behind Pmv Pharmaceuticals and NewAmsterdam Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.